Relieving anxiety by entering the operating room on foot
To the Editor: We hypothesized that entering the operating room (OR) lying on a gurney increased anxiety, and investigated the effects of entering on foot compared to gurney transport with premedication.
From October 1998 through September 2000, we evaluated the preoperative anxiety of patients aged 15 to 80 yr old with clear consciousness who received elective surgery under general anesthesia at Suwa Red Cross Hospital. With the approval of hospital Ethics Committee and informed consent, 672 patients were premedicated with hydroxyzine (50-100 mg) and atropine sulfate (0.4-0.5 mg) intramuscularly and transferred to the OR on a gurney 30 min later (gurney group); while 686 patients entered the OR on foot without premedication (on-foot group). Two nurses, who greeted the patient at the OR entrance, assessed the patient's psychological status based on the patient's replies and physical signs of facial expression, manner of speech or spontaneous movement of limbs, and classified it into one of four categories: oversedated, sedated, calm or mildly anxious, and highly anxious. Gurney group and on-foot group were similar in age (55.3 ± 15.5 and 54.3 ± 16.9 yr old), gender (51.0 and 50.9% female), and surgical field distribution.
Our results show a significantly greater number of highly anxious patients, more sedated patients notwithstanding, among the gurney group compared to the on-foot group (Table) . 4 There are possible explanations for the result. Walking and the accompanying chatter may have relaxed patients, while lying on a gurney accelerated preoperative anxiety. Preoperative transport on a gurney may be stressful to patients because it is difficult to see and talk to other people looking down at them. In our experience, the apparent underestimation of the effect of premedication may be due to evaluation of patients upon entrance in the OR since, in many previous reports, this evaluation was made on the ward and the stress of transport was eliminated. Moreover, some patients in the gurney group expressed anxiety despite being in a drowsy state with their eyes closed. While hydroxyzine is a relatively mild premedicant, 1 more potent sedatives have side effects like respiratory depression. 2 Regardless of anesthesiologists' preferences, patients do not always appreciate preoperative sedation and amnesia 3 that may lead to impersonal treatment or even mistakes. Our study suffers from several limitations, e.g., observers were unblinded and validated psychological questionnaires to measure anxiety were not used. Nonetheless, we feel that the results of this preliminary study suggest that entering the OR on foot contributes to the reduction of preoperative anxiety. 
Preventing contamination of propofol infusions
To the Editor: Lorenz et al. 1 examined the bacterial contamination rate of propofol syringes and infusions that were prepared according to: a) the manufacturer's strict guidelines for aseptic handling technique; and b) an alternate method of refilling syringes using what the authors refer to as a closed loop system. While the alternate method may be more efficient and economical, it cannot be properly described as a closed loop system because the stem of the syringe plunger may come into contact with the inside of the syringe during repeated filling. This is a potential source of contamination not associated with single use. Although the authors detected no difference in bacterial contamination rates between the two methods, the sample size of 80 patients is small and we remain concerned that anesthesiologists will endanger patients and assume increased medico-legal risks if they do not follow the manufacturer's recommended procedure. 
Short-and long-term efficacy of oral ketamine in eight chronic-pain patients
To the Editor: Ketamine, as a N-methyl-D-aspartate antagonist, has a noticeable analgesic action and can be used for the treatment of neuropathic pain. [1] [2] [3] We studied the effect of oral ketamine in eight chronic neuropathicpain patients.
Patients relieved by the iv infusion of ketamine were entered in the study (Table) . After informed consent had been obtained, eight patients were randomly assigned to receive oral ketamine syrup (0.5 mg·kg -1 ) or the same volume of a placebo syrup every six hours for a week. After seven days the pain was rated by the patient on a visual analogue scale, and allodynia was rated on a four-point verbal rating scale. The plasma concentration of ketamine was measured at five, ten, 30, 60, 120, and 180 min after its administration in all patients on the seventh day. In this short-term study, the severity of the pain and allodynia was reduced by oral ketamine administration about 15 min after administration, and improvement lasted from six to eight hours. Two of the eight subjects complained of headache relieved by loxoprofen. One patient complained of nightmares reduced by the coadministration of diazepam and of slight dizziness that required no treatment. Ketamine plasma levels were below the limit of detection (0.05 µg·mL -1 ) in all patients despite good pain relief.
In addition, we assessed pain relief and side effects in four of eight patients treated with oral ketamine for more than nine months. We also measured the plasma concentration of ketamine 12 hr after oral administration in two patients. In the long-term study, the severity of pain during daily life was reduced in all four patients (Table) . We could reduce the dose of oral ketamine in two patients and of other analgesics in all patients. The plasma concentration of ketamine was 0.46 µg·mL -1 in patient one and under the limit of detection in patient four.
